Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
3.04M
-
Shares change
-
-221K
-
Total reported value, excl. options
-
$1.31M
-
Value change
-
-$116K
-
Put/Call ratio
-
0.33
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$0.43
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2022
29 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2022.
IGC Pharma, Inc. - COM NEW (IGC) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.04M shares
.
Largest 10 shareholders include BlackRock Inc. (744K shares), VANGUARD GROUP INC (646K shares), RENAISSANCE TECHNOLOGIES LLC (321K shares), GEODE CAPITAL MANAGEMENT, LLC (303K shares), STATE STREET CORP (184K shares), DEARBORN PARTNERS LLC (134K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (122K shares), Vident Investment Advisory, LLC (122K shares), MILLENNIUM MANAGEMENT LLC (82.1K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (69K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.